China Cord Blood Corp. (NYSE:CO) rose 3.4% during trading on Friday . The stock traded as high as $5.13 and last traded at $5.11, with a volume of 185,394 shares changing hands. The stock had previously closed at $4.94.

CO has been the topic of several recent analyst reports. Zacks Investment Research upgraded shares of China Cord Blood Corp. from a “sell” rating to a “hold” rating in a research note on Thursday, August 11th. TheStreet downgraded shares of China Cord Blood Corp. from a “buy” rating to a “hold” rating in a research note on Thursday, August 4th. Five research analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $7.00.

The stock has a 50-day moving average of $5.39 and a 200 day moving average of $5.87. The company has a market cap of $416.43 million and a price-to-earnings ratio of 27.66.

China Cord Blood Corp. (NYSE:CO) last announced its quarterly earnings results on Tuesday, June 14th. The company reported $0.03 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.03. The business had revenue of $24.30 million for the quarter. Analysts forecast that China Cord Blood Corp. will post $0.17 earnings per share for the current year.

China Cord Blood Corporation is principally engaged in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. The Company provides cord blood testing, processing and storage services under the direction of subscribers. The Company also preserves cord blood units donated by the public, provides matching services on such donated units and delivers matching units to patients in need of transplants.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.